Bessemer Group Inc. increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 17.2% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 515,431 shares of the healthcare conglomerate's stock after acquiring an additional 75,675 shares during the period. Bessemer Group Inc. owned about 0.06% of UnitedHealth Group worth $189,204,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. City State Bank boosted its stake in shares of UnitedHealth Group by 5.6% during the third quarter. City State Bank now owns 471 shares of the healthcare conglomerate's stock valued at $173,000 after purchasing an additional 25 shares in the last quarter. Murphy Pohlad Asset Management LLC increased its stake in shares of UnitedHealth Group by 0.5% in the third quarter. Murphy Pohlad Asset Management LLC now owns 5,305 shares of the healthcare conglomerate's stock valued at $1,947,000 after buying an additional 25 shares during the period. LFG Wealth Partners LLC raised its holdings in UnitedHealth Group by 3.3% in the 2nd quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate's stock valued at $355,000 after buying an additional 27 shares during the last quarter. Synergy Financial Group LTD boosted its position in UnitedHealth Group by 3.1% during the 2nd quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate's stock worth $369,000 after buying an additional 27 shares during the period. Finally, Ares Financial Consulting LLC grew its holdings in UnitedHealth Group by 7.2% during the 2nd quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate's stock worth $174,000 after acquiring an additional 28 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several equities analysts have issued reports on the stock. New Street Research set a $402.00 price target on shares of UnitedHealth Group in a research report on Friday, October 9th. Bank of America reiterated a "buy" rating and set a $450.00 price target on shares of UnitedHealth Group in a report on Monday, July 20th. Wall Street Zen raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Saturday, August 8th. Stephens set a $500.00 price objective on UnitedHealth Group in a report on Friday, October 16th. Finally, Piper Sandler lifted their target price on UnitedHealth Group from $502.00 to $504.00 and gave the stock an "overweight" rating in a report on Wednesday, October 14th. Twenty equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $463.93.
View Our Latest Stock Report on UNH
Insider Buying and Selling
In related news, CEO Patrick Conway sold 1,169 shares of the firm's stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares of the company's stock, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.19% of the stock is owned by corporate insiders.
Key Stories Impacting UnitedHealth Group
Here are a few of the latest stories about UNH:
UnitedHealth Group Trading Up 0.0%
NYSE:UNH opened at $407.62 on Monday. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74. The firm's fifty day moving average is $391.36 and its 200-day moving average is $365.66. The firm has a market cap of $365.23 billion, a P/E ratio of 23.28, a P/E/G ratio of 1.47 and a beta of 0.51.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, topping analysts' consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business had revenue of $112.72 billion during the quarter, compared to the consensus estimate of $111.31 billion. During the same quarter last year, the firm earned $2.59 earnings per share. UnitedHealth Group's quarterly revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, December 7th will be given a dividend of $2.32 per share. The ex-dividend date is Monday, December 7th. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. UnitedHealth Group's dividend payout ratio is presently 53.00%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
Recommended Stories
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.